Literature DB >> 6726427

Methods of measuring splenic blood flow and platelet transit time with In-111-labeled platelets.

A M Peters, M J Walport, R N Bell, J P Lavender.   

Abstract

Following bolus intravenous injection of In-111-labeled autologous platelets in humans, splenic blood flow (SBF) was measured by compartmental analysis of the equilibration of platelets between blood and the intrasplenic platelet pool. The result correlated closely (r = 0.94, p less than 0.001) with SBF measured from analysis of the first-pass time-activity curve recorded over the spleen by external detection. The intrasplenic platelet transit time (tp), measured concurrently with SBF from compartmental analysis, correlated closely (r = 0.78, p less than 0.001) with tp measured from deconvolution analysis. These correlations appear to support the use of compartmental analysis of the equilibration of radiolabeled platelets between blood and the intrasplenic platelet pool as a valid technique for the simultaneous measurement of SBF and tp. Both of these parameters have potential clinical usefulness for the understanding of intrasplenic platelet kinetics in a variety of disorders.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6726427

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  3 in total

1.  Blood platelet kinetics in normal subjects modelled by compartmental analysis.

Authors:  M A Sweetlove; M G Lötter; J P Roodt; P N Badenhorst; H F Kotzé; A D Heyns
Journal:  Eur J Nucl Med       Date:  1992

2.  The clearance kinetics of autologous RhD-positive erythrocytes coated ex vivo with novel recombinant and monoclonal anti-D antibodies.

Authors:  G E Chapman; J R Ballinger; M J Norton; D R Parry-Jones; N A Beharry; C Cousins; C H Dash; A M Peters
Journal:  Clin Exp Immunol       Date:  2007-08-03       Impact factor: 4.330

3.  The splenic extraction ratio of antibody-coated erythrocytes and its response to plasma exchange and pulse methylprednisolone.

Authors:  M J Walport; A M Peters; K B Elkon; C D Pusey; J P Lavender; G R Hughes
Journal:  Clin Exp Immunol       Date:  1985-06       Impact factor: 4.330

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.